An Open-label Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif (Interferon Beta-1a) in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2016
At a glance
- Drugs Interferon beta-1a (Primary) ; Peginterferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Acronyms COMPARE
- Sponsors Biogen
- 08 Apr 2016 Results published in the British Journal of Clinical Pharmacology
- 04 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov .